IBM has inked an agreement to buy Merge Healthcare for $1 billion. The acquisition would move its Watson computer system beyond natural language and into medical images, a field in which IBM thinks its computing power can improve the detection of changes and anomalies.
IBM's Jeopardy-winning Watson is known for its natural language abilities, but it will soon read medical images too, thanks to the company's planned acquisition of Chicago's Merge Healthcare for $1 billion.
IBM has continued its push into healthcare and research by striking deals with electronic health record software provider Epic, Mayo Clinic and 14 cancer institutes.
IBM is unleashing Watson on healthcare. The tech heavyweight's brand-new healthcare business unit says it will team up with 14 top cancer centers to turn genetic data into personalized patient treatments.
IBM is rolling out at an enhanced, cancer-fighting version of its Jeopardy-winning supercomputer Watson at more than a dozen hospitals across the U.S. The move demonstrates the advent of Big Data, cognitive technology and personalized medicine in healthcare.
IBM is unleashing Watson on healthcare. Fresh off a triad of big-name deals--Apple, Medtronic and Johnson & Johnson--the tech giant's brand-new healthcare business unit says it will work with 14 top cancer centers to turn genetic data into personalized patient treatments.
Apple just gained a powerful ally in its push to make ResearchKit a core component of the health research toolkit. The Silicon Valley tech giant has tapped IBM for access to Watson, the data-mining and predictive analytics capabilities of which will be applied to health research.
IBM's artificial intelligence tool Watson is an expert at Jeopardy, but it can't answer the question as to whether the technology should be regulated as a medical device. That decision rests with Congress and the FDA, or perhaps lobbyists.
Pathway Genomics had a busy week. The San Diego, CA-based genetic testing laboratory began by securing an investment from IBM that will also give it access to Watson, before going on to form a cancer research collaboration with a registry created by researchers from Memorial Sloan Kettering, Mayo Clinic, Dana-Farber and other organizations.
IBM has made another foray into healthcare research. The latest collaboration sees the tech veteran team up with Cleveland Clinic to use Watson in genomics cancer research.